Cardiosave Hybrid Intra-Aortic Balloon Pumps (IABP), Model Number 0998-00-0800-55, Part Number 09...

FDA Device Recall #Z-1907-2023 — Class III — May 4, 2023

Recall Summary

Recall Number Z-1907-2023
Classification Class III — Low risk
Date Initiated May 4, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Datascope Corp.
Location Mahwah, NJ
Product Type Devices
Quantity 4 units

Product Description

Cardiosave Hybrid Intra-Aortic Balloon Pumps (IABP), Model Number 0998-00-0800-55, Part Number 0998-00-0800-XX

Reason for Recall

The digital IFUs provided with the Cardiosave IABP during the software update to version D.00 incorrectly annotated compliance to standard 60601-1-12:2014 within the updated IFU.

Distribution Pattern

International distribution in the country of Germany.

Lot / Code Information

UDI-DI: 10607567108414; Serial Numbers: CB286971I8 CB283804G8 CB283867G8 CB283522G8

Other Recalls from Datascope Corp.

Recall # Classification Product Date
Z-1487-2026 Class II CS300 IABP. Software Version CS300 IABP C.01. Jan 23, 2026
Z-1486-2026 Class II CS100 IABP. Software Version CS100 IABP Q.01. Jan 23, 2026
Z-0916-2026 Class II Cardiosave Hybrid. Intra-Aortic Balloon Pump sy... Nov 4, 2025
Z-0917-2026 Class II Cardiosave Rescue. Intra-Aortic Balloon Pump sy... Nov 4, 2025
Z-0932-2026 Class III Cardiosave Rescue Oct 23, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.